Adverum Biotechnologies I...

NASDAQ: ADVM · Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT

Adverum Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-130.93M -122.12M -154.54M -145.54M
Depreciation & Amortization
3.65M 5.64M 6.53M 4.64M
Stock-Based Compensation
14.35M 17.57M 20.08M 25.19M
Other Working Capital
1.17M -8.14M 19.04M 5.67M
Other Non-Cash Items
19.55M 16.51M -51K -25K
Deferred Income Tax
n/a n/a n/a 3.83M
Change in Working Capital
911K -8.51M 19.89M 4.06M
Operating Cash Flow
-92.46M -90.9M -108.09M -107.83M
Capital Expenditures
-388K -808K -11.82M -15.12M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-101.9M -36.72M -104.36M -407.51M
Sales Maturities Of Investments
60.4M 134.4M 257.9M 501.35M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-41.89M 96.88M 141.72M 78.71M
Debt Repayment
n/a n/a n/a -240K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
642K -420K n/a 952K
Financial Cash Flow
120M 69K 607K 2.4M
Net Cash Flow
-14.35M 6.04M 34.24M -26.73M
Free Cash Flow
-92.85M -91.71M -119.91M -122.95M